MacGowan Guy A, Crossland David S, Hasan Asif, Schueler Stephan
1 Department of Cardiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK ; 2 Institute of Medical Genetics, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK ; 3 Department of Paediatric Cardiology, 4 Department of Paediatric Cardiothoracic Surgery, 5 Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.
J Thorac Dis. 2015 Mar;7(3):527-31. doi: 10.3978/j.issn.2072-1439.2015.01.07.
The nature and size of the heart transplant waiting list has changed over recent years, most obviously with a larger number of patients on the list with ventricular assist devices (VADs). Given the limited numbers of available donors it is time to re-evaluate who is actually placed on the list. Evidence suggests that many patients with stable ambulatory heart failure might have a limited survival benefit from heart transplantation, so these patients may be an obvious target when considering how to reduce the size of the list. How stable VAD patients or adult congenital heart disease patients with declining symptoms should be prioritized for transplantation is unclear. Nevertheless we do need effective and simple models that can predict which of these disparate groups would benefit from transplantation so that we can fairly distribute this scarce commodity to the sickest patients that would benefit the most from transplantation.
近年来,心脏移植等待名单的性质和规模发生了变化,最明显的是名单上使用心室辅助装置(VAD)的患者数量增加。鉴于可用供体数量有限,现在是重新评估实际列入名单的人员的时候了。有证据表明,许多症状稳定的非卧床心力衰竭患者可能从心脏移植中获得的生存益处有限,因此在考虑如何缩小名单规模时,这些患者可能是一个明显的目标。目前尚不清楚VAD患者或症状逐渐恶化的成人先天性心脏病患者在移植时应如何确定优先顺序。然而,我们确实需要有效且简单的模型,能够预测这些不同群体中哪些人将从移植中获益,以便我们能够将这种稀缺资源公平地分配给最病重且能从移植中获益最大的患者。